potent and selective antitumor activity

Satoshi Funakoshi, Osamu Asai, Dan L. Longo, Zhi-Gang Tian, Douglas K. Ferris, Michael Widmer, William J. Murphy, In Vivo Antitumor Effects of Unconjugated CD30 Monoclonal Antibodies on Human Anaplastic Large-Cell Lymphoma Xenografts Cancer Research. ,vol. 55, pp. 5335- 5341 ,(1995)

E. R. Podack, K. J. Olsen, M. A. Bowen, D. Avila, Lirong Cheng, Functional effects of CD30 on a large granular lymphoma cell line, YT. Inhibition of cytotoxicity, regulation of CD28 and IL-2R, and induction of homotypic aggregation. Journal of Immunology. ,vol. 151, pp. 5896- 5906 ,(1993)

Roberto Gerli, Costantino Pitzalis, Onelia Bistoni, Brunangelo Falini, Vincenzo Costantini, Anna Russano, Claudio Lunardi, CD30+ T cells in rheumatoid synovitis: mechanisms of recruitment and functional role. Journal of Immunology. ,vol. 164, pp. 4399- 4407 ,(2000) , 10.4049/JIMMUNOL.164.8.4399

Mansoor N. Saleh, Steve Sugarman, James Murray, Joy B. Ostroff, Diane Healey, Dennie Jones, Carol R. Daniel, Donna LeBherz, Hannah Brewer, Nicole Onetto, Albert F. LoBuglio, Phase I Trial of the Anti–Lewis Y Drug Immunoconjugate BR96-Doxorubicin in Patients With Lewis Y–Expressing Epithelial Tumors Journal of Clinical Oncology. ,vol. 18, pp. 2282- 2292 ,(2000) , 10.1200/JCO.2000.18.11.2282

S. A. McMillan, G. V. McDonnell, J. P. Douglas, S. A. Hawkins, Evaluation of the clinical utility of cerebrospinal fluid (CSF) indices of inflammatory markers in multiple sclerosis. Acta Neurologica Scandinavica. ,vol. 101, pp. 239- 243 ,(2000) , 10.1034/J.1600-0404.2000.101004239.X

Louis M Weiner, Gregory P Adams, New approaches to antibody therapy Oncogene. ,vol. 19, pp. 6144- 6151 ,(2000) , 10.1038/SJ.ONC.1204000

Alan F. Wahl, Karen L. Donaldson, Craig Faircnild, Frank Y.F. Lee, Scott A. Foster, G. William Demers, Denise A. Galloway, Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis Nature Medicine. ,vol. 2, pp. 72- 79 ,(1996) , 10.1038/NM0196-72

Pier Luigi Tazzari, Andrea Bolognesi, Daniela de Totero, Brunangelo Falini, Roberto M. Lemoli, Marco R. Soria, Stefano Pileri, Marco Gobbi, Harald Stein, Leonardo Flenghi, Massimo F. Martelli, Fiorenzo Stirpe, Ber-H2 (anti-CD30)-saporin immunotoxin: a new tool for the treatment of Hodgkin's disease and CD30+ lymphoma: in vitro evaluation. British Journal of Haematology. ,vol. 81, pp. 203- 211 ,(1992) , 10.1111/J.1365-2141.1992.TB08208.X

Horst Dürkop, Hans‐Dieter Foss, Florian Eitelbach, Ioannis Anagnostopoulos, Ute Latza, Stefano Pileri, Harald Stein, None, Expression of the CD30 antigen in non-lymphoid tissues and cells. The Journal of Pathology. ,vol. 190, pp. 613- 618 ,(2000) , 10.1002/(SICI)1096-9896(200004)190:5<613::AID-PATH559>3.0.CO;2-0

H. Dalton King, Gene M. Dubowchik, Harold Mastalerz, David Willner, Sandra J. Hofstead, Raymond A. Firestone, Shirley J. Lasch, Pamela A. Trail, Monoclonal antibody conjugates of doxorubicin prepared with branched peptide linkers: Inhibition of aggregation by methoxytriethyleneglycol chains Journal of Medicinal Chemistry. ,vol. 45, pp. 4336- 4343 ,(2002) , 10.1021/JM020149G